A phase II study to evaluate the need for > two doses of nivolumab + ipilimumab combination (combo) immunotherapy.

Authors

Suresh G. Nair MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2020

Volume

38

Issue

15

Published In/Presented At

Michael A. Postow et al.,

A phase II study to evaluate the need for > two doses of nivolumab + ipilimumab combination (combo) immunotherapy.. JCO 38, 10003-10003(2020).

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article